By documenting your day-to-day, you can start to find what foods, meal sizes, and meal timing might be causing your nausea and make adjustments with the advice of your doctor or pharmacist
The addition of glucagon receptor agonism introduces some safety considerations not seen with GLP-1 or dual GLP-1/GIP agonists alone
Tirzepatide may be better for patients who have not seen success with other programs, who have insulin resistance, or who want to pursue more aggressive weight loss goals
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
Your Safety Doctor-Supervised Weight Loss Unlike online prescriptions or sketchy sources, our program is fully monitored by a licensed physician with expertise in obesity medicine
Strategic meal timing, eating smaller portions, and following a tirzepatide diet plan can help manage this significantly